Your browser doesn't support javascript.
loading
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma.
Liu, Tsung-Hao; Shao, Yu-Yun; Lu, Li-Chun; Shen, Ying-Chun; Hsu, Chiun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii.
Affiliation
  • Liu TH; a Department of Internal Medicine , National Taiwan University Hospital Hsin-Chu Branch , Hsinchu , Taiwan.
  • Shao YY; b Department of Oncology , National Taiwan University Hospital , Taipei , Taiwan.
  • Lu LC; d Graduate Institute of Oncology , National Taiwan University College of Medicine , Taipei , Taiwan.
  • Shen YC; b Department of Oncology , National Taiwan University Hospital , Taipei , Taiwan.
  • Hsu C; d Graduate Institute of Oncology , National Taiwan University College of Medicine , Taipei , Taiwan.
  • Lin ZZ; e Department of Medical Oncology , National Taiwan University Cancer Center , Taipei , Taiwan.
  • Hsu CH; b Department of Oncology , National Taiwan University Hospital , Taipei , Taiwan.
  • Cheng AL; d Graduate Institute of Oncology , National Taiwan University College of Medicine , Taipei , Taiwan.
Expert Rev Gastroenterol Hepatol ; 13(7): 615-621, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31132887

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Clinical Trials as Topic / Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: Expert Rev Gastroenterol Hepatol Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Clinical Trials as Topic / Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: Expert Rev Gastroenterol Hepatol Year: 2019 Document type: Article